Department of Chemistry and Biochemistry, University of California, San Diego La Jolla, California, USA.
Molecular Bacteriology Laboratory, European Plotkin Institute for Vaccinology, ULB, Brussels, Belgium.
J Biol Chem. 2024 Jul;300(7):107478. doi: 10.1016/j.jbc.2024.107478. Epub 2024 Jun 13.
Antigenically sequence variable M proteins of the major bacterial pathogen Streptococcus pyogenes (Strep A) are responsible for recruiting human C4b-binding protein (C4BP) to the bacterial surface, which enables Strep A to evade destruction by the immune system. The most sequence divergent portion of M proteins, the hypervariable region (HVR), is responsible for binding C4BP. Structural evidence points to the conservation of two C4BP-binding sequence patterns (M2 and M22) in the HVR of numerous M proteins, with this conservation applicable to vaccine immunogen design. These two patterns, however, only partially explain C4BP binding by Strep A. Here, we identified several M proteins that lack these patterns but still bind C4BP and determined the structures of two, M68 and M87 HVRs, in complex with a C4BP fragment. Mutagenesis of these M proteins led to the identification of amino acids that are crucial for C4BP binding, enabling formulation of new C4BP-binding patterns. Mutagenesis was also carried out on M2 and M22 proteins to refine or generate experimentally grounded C4BP-binding patterns. The M22 pattern was the most prevalent among M proteins, followed by the M87 and M2 patterns, while the M68 pattern was rare. These patterns, except for M68, were also evident in numerous M-like Enn proteins. Binding of C4BP via these patterns to Enn proteins was verified. We conclude that C4BP-binding patterns occur frequently in Strep A strains of differing M types, being present in their M or Enn proteins, or frequently both, providing further impetus for their use as vaccine immunogens.
主要细菌病原体化脓链球菌(酿脓链球菌)的抗原序列可变 M 蛋白负责将人 C4b 结合蛋白(C4BP)募集到细菌表面,使酿脓链球菌能够逃避免疫系统的破坏。M 蛋白中序列差异最大的部分,即高变区(HVR),负责与 C4BP 结合。结构证据表明,在许多 M 蛋白的 HVR 中存在两种 C4BP 结合序列模式(M2 和 M22)的保守性,这种保守性适用于疫苗免疫原设计。然而,这两种模式仅部分解释了酿脓链球菌与 C4BP 的结合。在这里,我们鉴定了一些缺乏这些模式但仍能与 C4BP 结合的 M 蛋白,并确定了两种 M 蛋白(M68 和 M87 HVR)与 C4BP 片段复合物的结构。这些 M 蛋白的突变导致鉴定出对 C4BP 结合至关重要的氨基酸,从而制定了新的 C4BP 结合模式。还对 M2 和 M22 蛋白进行了突变,以完善或生成基于实验的 C4BP 结合模式。M22 模式在 M 蛋白中最为普遍,其次是 M87 和 M2 模式,而 M68 模式则很少见。除了 M68 之外,这些模式在许多类似 M 的 Enn 蛋白中也很明显。通过这些模式与 Enn 蛋白结合 C4BP 得到了验证。我们得出结论,C4BP 结合模式在不同 M 型酿脓链球菌菌株中经常出现,存在于其 M 或 Enn 蛋白中,或经常同时存在于两种蛋白中,这为将其用作疫苗免疫原提供了进一步的动力。